Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 459
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 95
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 35
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
HIV/AIDS Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

2,424 Results (Page 23 of 122)
- Relevance
  Sort by

Pharmaceutical Drug Delivery Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3981EUR$4,490USD£3,452GBP

High Potency Active Pharmaceutical Ingredients Market by Type (Biologics, Small Molecule), Therapeutic Area (Cardiology, Infectious Disease, Neurology), Source, Dosage Form, Manufacturing Process, End User - Global Forecast 2025-2030

 Report
August 2025
191 Pages
Global

From

€3143EUR$3,545USD£2,725GBP

€3493EUR$3,939USD£3,028GBP

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

 Drug Pipelines
August 2023
580 Pages
United States

From

€3352EUR$3,780USD£2,906GBP

€3724EUR$4,200USD£3,229GBP

Lung Cancer Diagnosis and Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
118 Pages
Global

From

€3500EUR$4,228USD£3,141GBP

$Refractory Metastatic Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image$

Refractory Metastatic Melanoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1108EUR$1,250USD£961GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Liver Disease Treatment Market Report by Treatment Type, Disease Type, End User, and Region 2025-2033

 Report
May 2025
150 Pages
Global

From

€2659EUR$2,999USD£2,305GBP

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

 Report
July 2023
3600 Pages
United States

From

€7182EUR$8,100USD£6,227GBP

€7980EUR$9,000USD£6,919GBP

Squamous Non-Small Cell Lung Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
99 Pages
Global

From

€3500EUR$4,228USD£3,141GBP

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
September 2022
194 Pages
Global

From

€4255EUR$4,799USD£3,689GBP

Europe Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule, By Product (Branded, Generics), By Type (Prescription, OTC), By Disease, By Age Group, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

 Report
June 2025
250 Pages
Europe

From

€5276EUR$5,950USD£4,574GBP

Pharmaceutical Market Size, Share & Trends Analysis Report by Molecule Type, Product, Type, Disease, Age Group, Route of Administration, Distribution Channel, and Region with Growth Forecasts, 2025-2030

 Report
February 2025
250 Pages
Global

From

€5276EUR$5,950USD£4,574GBP

Polycystic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
109 Pages
Global

From

€1773EUR$2,000USD£1,537GBP

Lyophilisation in Pharmaceutical Market Report 2023-2033

 Report
November 2022
260 Pages
Global

From

€4716EUR$5,504USD£3,950GBP

Critical Care Therapeutics - Global Strategic Business Report

 Report
August 2025
280 Pages
Global

From

€5187EUR$5,850USD£4,497GBP

Pharmerging - Global Strategic Business Report

 Report
August 2025
184 Pages
Global

From

€5187EUR$5,850USD£4,497GBP

Anti-Infectives - Global Strategic Business Report

 Report
August 2025
116 Pages
Global

From

€5187EUR$5,850USD£4,497GBP

Oral Antivirals - Global Strategic Business Report

 Report
August 2025
380 Pages
Global

From

€5187EUR$5,850USD£4,497GBP

Pseudomonas Aeruginosa Infection Treatment - Global Strategic Business Report

 Report
August 2025
273 Pages
Global

From

€5187EUR$5,850USD£4,497GBP

Encephalitis Treatment - Global Strategic Business Report

 Report
August 2025
478 Pages
Global

From

€5187EUR$5,850USD£4,497GBP

Neglected Tropical Disease Treatment - Global Strategic Business Report

 Report
August 2025
294 Pages
Global

From

€5187EUR$5,850USD£4,497GBP

2,424 Results (Page 23 of 122)
- 1
- 21
- 22
- 23
- 24
- 25

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.